Novocure (NVCR) Tops Q1 EPS by 3c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $34.9 million versus the consensus estimate of $36.96 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge